An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization
- 27 July 2005
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 19 (12) , 1668-1670
- https://doi.org/10.1096/fj.04-2030fje
Abstract
Inflammation in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE), is manifested by changes in matrix metalloproteinase (MMP) expression and in the ratio of T helper (Th) 1 and 2 effector cytokines. Here, we provide a comprehensive documentation of MMPs in EAE and report that of all the MMPs that could be measured at peak disease in spinal cord tissue, MMP-12 was the most highly up-regulated. In contrast to previously published findings of MMPs in EAE, this increase in MMP-12 expression was associated with protection, as MMP-12 null mice had significantly worse maximum severity and EAE disease burden compared with wild-type (WT) controls. When spleen and lymph node cells were removed from EAE-afflicted WT and MMP-12 null mice at the same disease score before divergence of disease and restimulated in vitro, the MMP-12 null cells had significantly higher Th1 to Th2 cytokine ratio. Measurements of the transcriptional regulators of T cell polarization revealed that MMP-12 null cells had increased T-bet and reduced GATA-3 expression, a condition that favors a Th1 bias. These results emphasize that specific MMPs can have beneficial roles in inflammation, and they implicate MMPs in T effector polarization for the first time.Keywords
Funding Information
- Canadian Institutes of Health Research
- Multiple Sclerosis Society of Canada
This publication has 37 references indexed in Scilit:
- Matrix metalloproteinases as modulators of inflammation and innate immunityNature Reviews Immunology, 2004
- A1 Adenosine Receptor Upregulation and Activation Attenuates Neuroinflammation and Demyelination in a Model of Multiple SclerosisJournal of Neuroscience, 2004
- The lineage decisions of helper T cellsNature Reviews Immunology, 2002
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Multiple Sclerosis: Deeper Understanding of Its Pathogenesis Reveals New Targets for TherapyAnnual Review of Neuroscience, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Cytokines and autoimmunityNature Reviews Immunology, 2002
- Regulation of Cell Survival by Secreted ProneurotrophinsScience, 2001
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994